SYDiscover the employees benefits and perks available to Systimmune employees.
Learn about the 6 benefits and perks Systimmune offers its employees.
15 PTO days per year.
11 paid holidays per year.
Company-provided sick leave.
Short-term (STD) and long-term (LTD) disability insurance provided.
100% paid employee premiums for medical, dental, and vision insurance.
401(k) plan with a 50% company match of up to 3% and a 5-year vesting schedule.
SY51-200 employees
2014
Jie D'Elia, Yi Zhu
Try our AI resume builder, interview practice, and cover letter generator for free. Then, unlock unlimited use for just $9/month.
View all toolsFind your next opportunity by exploring profiles of companies that are similar to Systimmune. Compare culture, benefits, and job openings on Himalayas.
Sign up now and join over 100,000 remote workers who receive personalized job alerts, curated job matches, and more for free!
Sign up now and join over 100,000 remote workers who receive personalized job alerts, curated job matches, and more for free!
Join the remote work revolution
Join over 100,000 job seekers who get tailored alerts and access to top recruiters.
AB
CB
GEFind your next opportunity by exploring profiles of companies that are similar to Systimmune. Compare culture, benefits, and job openings on Himalayas.
Adaptive Biotechnologies is a commercial-stage biotechnology company that harnesses the adaptive immune system's biology to transform disease diagnosis and treatment, offering an immune-sequencing platform for research and clinical diagnostics.
Coherus BioSciences is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer.
Genmab A/S is an innovative biotechnology company focused on developing antibody therapeutics to improve patient care, particularly in oncology.
Adaptimmune is a clinical-stage biopharmaceutical company focused on developing innovative therapies for solid tumors using engineered T-cell technologies.
Legend Biotech is a commercial-stage biotechnology firm specializing in the development of innovative therapies for cancer treatment.
Replimune is focused on developing innovative oncolytic immunotherapies aimed at treating difficult-to-treat cancers by harnessing the immune system.
United States
